145 related articles for article (PubMed ID: 28782877)
1. Insurance coverage decisions for pediatric proton therapy.
Ojerholm E; Hill-Kayser CE
Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28782877
[TBL] [Abstract][Full Text] [Related]
2. Young Adult Populations Face Yet Another Barrier to Care With Insurers: Limited Access to Proton Therapy.
Bishop AJ; Livingston JA; Ning MS; Valdez ID; Wages CA; McAleer MF; Paulino AC; Grosshans DR; Woodhouse KD; Tao R; Roth ME; Gunn GB; McGovern SL
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1496-1504. PubMed ID: 33677051
[TBL] [Abstract][Full Text] [Related]
3. Insurance Approval for Proton Beam Therapy and its Impact on Delays in Treatment.
Gupta A; Khan AJ; Goyal S; Millevoi R; Elsebai N; Jabbour SK; Yue NJ; Haffty BG; Parikh RR
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):714-723. PubMed ID: 30557673
[TBL] [Abstract][Full Text] [Related]
4. The Insurance Approval Process for Proton Radiation Therapy: A Significant Barrier to Patient Care.
Ning MS; Gomez DR; Shah AK; Kim CR; Palmer MB; Thaker NG; Grosshans DR; Liao Z; Chapman BV; Brooks ED; Tang C; Rosenthal DI; Garden AS; Frank SJ; Gunn GB
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):724-733. PubMed ID: 30557675
[TBL] [Abstract][Full Text] [Related]
5. Doing poorly by doing good: the bottom line of proton therapy for children.
Johnstone PA; Kerstiens J
J Am Coll Radiol; 2014 Oct; 11(10):995-7. PubMed ID: 24881504
[TBL] [Abstract][Full Text] [Related]
6. Comment on: Insurance coverage decisions for pediatric proton therapy.
Schefft M
Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28895289
[No Abstract] [Full Text] [Related]
7. Commercial Insurance Coverage of Advanced Radiation Therapy Techniques Compared With American Society for Radiation Oncology Model Policies.
Verma V; Ludmir EB; Mesko SM; Brooks ED; Augustyn A; Milano MT; Lin SH; Chang JY; Welsh JW
Pract Radiat Oncol; 2020; 10(5):324-329. PubMed ID: 31446147
[TBL] [Abstract][Full Text] [Related]
8. Reply to comment on: Insurance coverage decisions for pediatric proton therapy.
Ojerholm E; Hill-Kayser CE
Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28921835
[No Abstract] [Full Text] [Related]
9. Preparation of pediatric patients for treatment with proton beam therapy.
Mizumoto M; Oshiro Y; Ayuzawa K; Miyamoto T; Okumura T; Fukushima T; Fukushima H; Ishikawa H; Tsuboi K; Sakurai H
Radiother Oncol; 2015 Feb; 114(2):245-8. PubMed ID: 25620062
[TBL] [Abstract][Full Text] [Related]
10. Proton therapy expansion under current United States reimbursement models.
Kerstiens J; Johnstone PA
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):235-40. PubMed ID: 24685152
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Proton Beam Therapy Use Among Patients With Newly Diagnosed Cancer in the US, 2004-2018.
Nogueira LM; Jemal A; Yabroff KR; Efstathiou JA
JAMA Netw Open; 2022 Apr; 5(4):e229025. PubMed ID: 35476066
[TBL] [Abstract][Full Text] [Related]
12. Proton beam therapy in pediatric oncology.
Baliga S; Yock TI
Curr Opin Pediatr; 2019 Feb; 31(1):28-34. PubMed ID: 30531222
[TBL] [Abstract][Full Text] [Related]
13. Patterns of Proton Beam Therapy Use in Clinical Practice between 2007 and 2019 in Korea.
Lee SU; Yang K; Moon SH; Suh YG; Yoo GS
Cancer Res Treat; 2021 Oct; 53(4):935-943. PubMed ID: 34015892
[TBL] [Abstract][Full Text] [Related]
14. Patterns of Care in Proton Radiation Therapy for Pediatric Central Nervous System Malignancies.
Odei B; Frandsen JE; Boothe D; Ermoian RP; Poppe MM
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):60-63. PubMed ID: 27816365
[TBL] [Abstract][Full Text] [Related]
15. A population-based assessment of proton beam therapy utilization in California.
Parikh-Patel A; Morris CR; Maguire FB; Daly ME; Kizer KW
Am J Manag Care; 2020 Feb; 26(2):e28-e35. PubMed ID: 32059097
[TBL] [Abstract][Full Text] [Related]
16. Early Experience of the First Single-Room Gantry Mounted Active Scanning Proton Therapy System at an Integrated Cancer Center.
Forsthoefel MK; Ballew E; Unger KR; Ahn PH; Rudra S; Pang D; Collins SP; Dritschilo A; Harter W; Paudel N; Collins BT; Lischalk JW
Front Oncol; 2020; 10():861. PubMed ID: 32547953
[No Abstract] [Full Text] [Related]
17. Photon and Proton Radiation Therapy Utilization in a Population of More Than 100 Million Commercially Insured Patients.
Waddle MR; Sio TT; Van Houten HK; Foote RL; Keole SR; Schild SE; Laack N; Daniels TB; Crown W; Shah ND; Miller RC
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1078-1082. PubMed ID: 28939229
[TBL] [Abstract][Full Text] [Related]
18. Ethical Allocation of Proton Therapy and the Insurance Review Process.
Grzywacz V; Quinn TJ; Wilson T; Reitemeier P; Navin M; Hamstra D; Anderson J; Chinnaiyan P; Stevens C; Kabolizadeh P
Pract Radiat Oncol; 2021; 11(5):e449-e458. PubMed ID: 33548544
[TBL] [Abstract][Full Text] [Related]
19. Reduced Survival in Bariatric Surgery Candidates Delayed or Denied by Lack of Insurance Approval.
Flanagan E; Ghaderi I; Overby DW; Farrell TM
Am Surg; 2016 Feb; 82(2):166-70. PubMed ID: 26874141
[TBL] [Abstract][Full Text] [Related]
20. Insurance Authorization and Access to Proton Therapy for Patients With Head and Neck Cancers.
McDonald MW; Bates JE; McCall NS; Goyal S; Liu Y; Rudra S; Remick JS; Tian S; El-Deiry MW; Saba NF; Stokes WA; Swinney E
Int J Radiat Oncol Biol Phys; 2023 Jun; 116(2):404-412. PubMed ID: 36889515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
